Insulet | PODD - 股票



金融业
股票价格
USD
资产
USD 3.19B
现金及等价物
USD 716.1M
销售成本
USD 215.2M
流动资产
USD 1.91B
流动负债
USD 680.1M
债务
USD 1.01B
EBIT
USD 146.3M
EBITDA
USD 194M
员工
3.9K
EPS每股收益
USD 1.44
股本和储备
USD 1.52B
销售毛利
USD 568.6M
债务利息支出
USD 9.2M
利息收入
USD 8.6M
贷款资金
USD 930.8M
市值
USD 11.98B
净收入
USD 101.6M
营业费用
USD 637.5M
营业利润
USD 146.3M
普通股股本
USD 70.35M
PE价格收益
55.08
税前利润
USD 140.2M
销售收入
USD 783.8M
销售和管理费用
USD 331.4M
股票
USD 452.6M
贸易债权人
USD 75M
应收帐款人
USD 516.9M


股票 更改 日
Abbott USD 6.99B 501M 2026-03
Align Technology USD 226.34M 1.82M 2025-12
AtriCure USD 78.49M 459K 2025-12
Avanos Medical USD 141.3M 6.7M 2026-03
Baxter International USD 2.32B 84M 2026-03
Becton, Dickinson and Co. USD 4.08B 191M 2025-12
Boston Scientific USD 3.12B 174M 2026-03
Cardinal Health USD 18.01B 2.11B 2026-03
Cooper Companies USD 846M 35M 2025-09
Dexcom USD 693.6M 64.5M 2026-03
Edwards Lifesciences USD 1.13B 14.7M 2025-12
Eli Lilly USD 14.53B 785M 2026-03
Globus Medical USD 759.28M 12.26M 2025-12
ICU Medical USD 615.86M 6.58M 2025-12
Inogen USD 25.08M 762K 2025-09
Insulet USD 452.6M 6.3M 2025-12
Integra LifeSciences USD 495.04M 2.3M 2026-03
J&J USD 14.58B 392M 2026-03
Masimo USD 338.6M 20.1M 2025-09
Medtronic USD 6.31B 153M 2025-12
Merit Medical Systems USD 352.39M 18.68M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Solventum Corp USD 1.09B 23M 2026-03
Stryker USD 5.42B 109M 2026-03
Tandem Diabetes Care USD 128.77M 8.51M 2025-12
Teleflex USD 802.46M 108.78M 2025-09
West Pharmaceutical Services USD 452.6M 8.7M 2026-03
Zimmer Biomet Holdings USD 2.25B 39.6M 2026-03